Surgeon: ASPS Youth Gender Surgery Ban Has No Medical
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Kavitha Ranganathan, a Harvard Medical School plastic surgeon and Mass General Brigham attending, says the ASPS's February position statement against gender-affirming surgery for anyone under 19 has produced a 'de facto nationwide ban' — she polled colleagues and found none still comfortable offering the care, even selectively.
- The American Society of Plastic Surgeons (ASPS) set an age-19 cutoff despite previously organizing symposia, funding grants, and openly supporting such care since Medicare/Medicaid began covering transition-related care in 2014; the organization once claimed surgery can help patients with gender dysphoria.
- The Trump administration has touted the ASPS statement as a 'victory for biological truth,' citing it as it pursues legal threats and federal grand jury subpoenas against hospitals and providers offering gender-affirming care.
- The ASPS's age-19 threshold has no medical or surgical literature to support it — cisgender women can get breast implants at 18 for cosmetic reasons, Ranganathan notes, even though 'the operation for both is exactly the same,' and the WHO's 10-19 adolescence window is not routinely used for surgical decisions.
- Gender-affirming surgery on minors is exceedingly rare, per a 2024 study: zero surgeries on anyone 12 and under in 2019 and rates of just 0.1–2.1 per 100,000 for ages 13–16, meaning the ban targets a virtually nonexistent practice.
- The ASPS has not banned the Brazilian butt lift — plastic surgery's highest-mortality aesthetic procedure — and instead formed a safety task force, undermining the patient-safety framing used to justify its gender-care position statement.
- Ranganathan, a former ASPS board member, points out the statement cites work by anti-trans groups like the Society for Evidence-Based Gender Medicine and HHS under Robert F. Kennedy Jr., rather than calling for regional centers of excellence or research protocols that could actually generate higher-quality evidence.
Why it matters: A specialty society that once championed gender-affirming surgical research has authored a statement — now embraced by the Trump administration in a legal fight courts have since found constitutionally problematic — that Ranganathan and other dissenting surgeons warn will chill care for adults as well as minors, with no evidence base for its specific age cutoff.
Ask SkimNews
